AU2002212201A1 - Maurotoxin, pi1 and hstx1 derivatives - Google Patents
Maurotoxin, pi1 and hstx1 derivativesInfo
- Publication number
- AU2002212201A1 AU2002212201A1 AU2002212201A AU1220102A AU2002212201A1 AU 2002212201 A1 AU2002212201 A1 AU 2002212201A1 AU 2002212201 A AU2002212201 A AU 2002212201A AU 1220102 A AU1220102 A AU 1220102A AU 2002212201 A1 AU2002212201 A1 AU 2002212201A1
- Authority
- AU
- Australia
- Prior art keywords
- derivatives
- residue
- maurotoxin
- replaced
- disulfide bridge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101001049892 Scorpio palmatus Potassium channel toxin alpha-KTx 6.2 Proteins 0.000 title abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 108010045489 Calcium-Activated Potassium Channels Proteins 0.000 abstract 1
- 102000005702 Calcium-Activated Potassium Channels Human genes 0.000 abstract 1
- 101001026236 Homo sapiens Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 abstract 1
- 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 abstract 1
- 102000003734 Voltage-Gated Potassium Channels Human genes 0.000 abstract 1
- 108090000013 Voltage-Gated Potassium Channels Proteins 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Insects & Arthropods (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Derivatives of Maurotoxin (MTX) in which the native disulfide bridge pattern (Cys3-Cys24, Cys9-Cys29, Cys19, Cys31-Cys34) has been disrupted are useful for the treatment of pathologies associated with dysfunctioning and/or activation of Ca2+-activated and/or voltage-gated K+ channel subtypes, such as IKCa1 or Kv1.2. In one group of derivatives, one or two of the amino acid residues of maurotoxin have been replaced by different amino acid residues resulting in the disulfide bridge pattern being changed to Cys3-Cys24, Cys9-Cys29, Cys13-Cys31, Cys19-Cys34. Exemplary substitutions include the Arg residue at position 14 and/or the Lys residue at position 15 replaced by a Gln residue and the Gly residue at position 33 replaced by an Ala residue. Pi1 and HsTx1 derivatives with disrupted native disulfide bridge patterns are similarly useful.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0021639.0 | 2000-09-04 | ||
| GB0021639A GB0021639D0 (en) | 2000-09-04 | 2000-09-04 | Maurotoxin derivatives |
| GB0024538.1 | 2000-10-06 | ||
| GB0024538A GB0024538D0 (en) | 2000-10-06 | 2000-10-06 | Maurotoxin pil and hstx1 derivatives |
| PCT/EP2001/010173 WO2002020596A2 (en) | 2000-09-04 | 2001-09-03 | Maurotoxin, pi1 and hstx1 derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002212201A1 true AU2002212201A1 (en) | 2002-03-22 |
Family
ID=26244958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002212201A Abandoned AU2002212201A1 (en) | 2000-09-04 | 2001-09-03 | Maurotoxin, pi1 and hstx1 derivatives |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040039167A1 (en) |
| EP (1) | EP1315747B1 (en) |
| AT (1) | ATE321778T1 (en) |
| AU (1) | AU2002212201A1 (en) |
| DE (1) | DE60118418T2 (en) |
| ES (1) | ES2261491T3 (en) |
| WO (1) | WO2002020596A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0414272D0 (en) * | 2004-06-25 | 2004-07-28 | Cellpep Sa | OsK1 derivatives |
| EP2081602A2 (en) * | 2006-10-25 | 2009-07-29 | Amgen Inc. | Toxin peptide therapeutic agents |
| US8420779B2 (en) * | 2007-05-22 | 2013-04-16 | Amgen Inc. | Compositions and methods for producing bioactive fusion proteins |
| DE202013104200U1 (en) | 2013-09-13 | 2013-10-10 | Flühs Drehtechnik GmbH | Single lever cartridge |
| WO2015061826A1 (en) | 2013-10-28 | 2015-05-07 | Monash University | Novel scorpion toxin analogue and method for treating autoimmune diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2121137A1 (en) * | 1991-10-12 | 1993-04-29 | Bob B. Buchanan | Use of thiol redox proteins for reducing disulfide bonds |
| US6187579B1 (en) * | 1993-10-28 | 2001-02-13 | Carlsberg A/S | Customized proteases |
| CA2253937A1 (en) * | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
| GB9627115D0 (en) * | 1996-12-31 | 1997-02-19 | Centre Nat Rech Scient | Alpha-amino-butyrate derivatives of venoms |
-
2001
- 2001-09-03 AU AU2002212201A patent/AU2002212201A1/en not_active Abandoned
- 2001-09-03 US US10/363,622 patent/US20040039167A1/en not_active Abandoned
- 2001-09-03 ES ES01980332T patent/ES2261491T3/en not_active Expired - Lifetime
- 2001-09-03 DE DE60118418T patent/DE60118418T2/en not_active Expired - Lifetime
- 2001-09-03 AT AT01980332T patent/ATE321778T1/en not_active IP Right Cessation
- 2001-09-03 WO PCT/EP2001/010173 patent/WO2002020596A2/en not_active Ceased
- 2001-09-03 EP EP01980332A patent/EP1315747B1/en not_active Expired - Lifetime
-
2008
- 2008-01-22 US US12/009,675 patent/US7829666B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002020596A3 (en) | 2002-08-01 |
| US20090062198A1 (en) | 2009-03-05 |
| US20040039167A1 (en) | 2004-02-26 |
| ES2261491T3 (en) | 2006-11-16 |
| US7829666B2 (en) | 2010-11-09 |
| EP1315747B1 (en) | 2006-03-29 |
| DE60118418T2 (en) | 2007-01-11 |
| WO2002020596A2 (en) | 2002-03-14 |
| EP1315747A2 (en) | 2003-06-04 |
| DE60118418D1 (en) | 2006-05-18 |
| ATE321778T1 (en) | 2006-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1877435T3 (en) | Glucagon-like peptide 2 (GLP-2) analogs | |
| UA102506C2 (en) | Selective glucagon-like-peptide-2 (glp-2) analogues | |
| WO2007056362A3 (en) | Glucagon analogs exhibiting physiological solubility and stability | |
| CY1113850T1 (en) | NEW INSULIN PRODUCERS | |
| DK1941867T3 (en) | Polypeptide with Modified Kunitz Domain | |
| ATE417595T1 (en) | KERATIN-BINDING POLYPEPTIDES | |
| PE20130615A1 (en) | POLYPEPTIDES OF THE VARIANT ACTIVIN RECEPTOR AND USE OF THEM | |
| BRPI0721259C1 (en) | compost, pharmaceutical composition, use of compost, and, process for making compost | |
| AU2002212201A1 (en) | Maurotoxin, pi1 and hstx1 derivatives | |
| EP1487854A4 (en) | NEW ISOFORMS OF VEGETABLE TENHEL CELL GROWTH HEMMER | |
| GB1601754A (en) | Pharmacologically active aligopeptide derivatives | |
| DK0918795T3 (en) | Antiangiogenic drugs for the treatment of cancer, arthritis and retinopathy | |
| BRPI0411820A (en) | pharmaceutical composition | |
| WO2006097432A3 (en) | Keratin-binding desmoplakin polypeptide sequences | |
| GEP20084464B (en) | Mutated neublastin | |
| EP2143730A3 (en) | Modified peptides and their use for the treatment of autoimmune diseases | |
| EP1586583A3 (en) | Compounds that block C5a complement receptor and their use in therapy | |
| WO2002083729A3 (en) | Polypeptides derived from amyloid precursor peptide (app) and their uses | |
| SE0001988D0 (en) | Novel polypeptides and use thereof | |
| ECSP003457A (en) | PROTEIN C DERIVATIVES | |
| CY1111301T1 (en) | POLYPeptides Derived from the Amyloid Peptide Precursor (ARP) PREMIUM AND THEIR USES | |
| ATE492637T1 (en) | PEPTIDES BINDING TO THE LCK-SH3 AND HCK-SH3 DOMAIN |